{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:38:13Z","timestamp":1792539493087,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000683","name":"Royal Society of Tropical Medicine and Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-14051-6","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:24:22Z","timestamp":1784859862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of uptake of praziquantel, chemotherapy for schistosomiasis treatment during mass drug administration in Busia County, Kenya"],"prefix":"10.1186","volume":"26","author":[{"given":"Paul Maina","family":"Ndung\u2019u","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titus","family":"Watitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyckliff","family":"Omondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Njomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"14051_CR1","unstructured":"World Health Organization. WHO guideline on control and elimination of human schistosomiasis. 1st ed. Geneva: World Health Organization. 2022. 1 p. https:\/\/www.who.int\/publications\/i\/item\/9789240041608. Accessed 20 Apr 2025."},{"issue":"1","key":"14051_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","volume":"77","author":"L Chitsulo","year":"2000","unstructured":"Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000;77(1):41\u201351. https:\/\/doi.org\/10.1016\/S0001-706X(00)00122-4.","journal-title":"Acta Trop"},{"issue":"26","key":"14051_CR3","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1812165","volume":"381","author":"AK Deol","year":"2019","unstructured":"Deol AK, Fleming FM, Calvo-Urbano B, Walker M, Bucumi V, Gnandou I, et al. Schistosomiasis \u2014 Assessing Progress toward the 2020 and 2025 Global Goals. N Engl J Med. 2019;381(26):2519\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1812165.","journal-title":"N Engl J Med"},{"issue":"1","key":"14051_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/pathogens9010028","volume":"9","author":"RH Mnkugwe","year":"2019","unstructured":"Mnkugwe RH, Minzi OS, Kinung\u2019hi SM, Kamuhabwa AA, Aklillu E. Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania. Pathogens. 2019;9(1):28. https:\/\/doi.org\/10.3390\/pathogens9010028.","journal-title":"Pathogens"},{"key":"14051_CR5","doi-asserted-by":"crossref","unstructured":"Kumela D, Ahmed A, Mehadi A, Wondimneh F, Ahmed M, Yusuf A, et al. Hepatosplenic schistosomiasis, treatment outcomes and associated factors among adult patients treated at public hospitals in the Harari Region of Ethiopia: retrospective cross-sectional study. Trans R Soc Trop Med Hyg. 2024. trae088.","DOI":"10.1093\/trstmh\/trae088"},{"key":"14051_CR6","doi-asserted-by":"publisher","first-page":"1168282","DOI":"10.3389\/fepid.2023.1168282","volume":"3","author":"FN Kiesolo","year":"2023","unstructured":"Kiesolo FN, Sampa M, Moonga G, Michelo C, Jacobs C. Coverage and predictors of the uptake of the mass drug administration of praziquantel chemotherapy for schistosomiasis in a selected urban setting in Zambia. Front Epidemiol. 2023;3:1168282. https:\/\/doi.org\/10.3389\/fepid.2023.1168282.","journal-title":"Front Epidemiol"},{"key":"14051_CR7","doi-asserted-by":"publisher","unstructured":"Diaz A, Walker M, Webster JP. Reaching the World Health Organization elimination targets for schistosomiasis: the importance of a one health perspective. Philosophical Trans Royal Soc B. 378(1887):p20220274. https:\/\/doi.org\/10.1098\/rstb.2022.0274.","DOI":"10.1098\/rstb.2022.0274"},{"issue":"1","key":"14051_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2049-9957-2-11","volume":"2","author":"A Dabo","year":"2013","unstructured":"Dabo A, Bary B, Kouriba B, Sankar\u00e9 O, Doumbo O. Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa). Infect Dis Poverty. 2013;2(1):11. https:\/\/doi.org\/10.1186\/2049-9957-2-11.","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"14051_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/tropicalmed6030109","volume":"6","author":"OP Aula","year":"2021","unstructured":"Aula OP, McManus DP, Jones MK, Gordon CA. Schistosomiasis with a Focus on Africa. TropicalMed. 2021;6(3):109. https:\/\/doi.org\/10.3390\/tropicalmed6030109.","journal-title":"TropicalMed"},{"issue":"1","key":"14051_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41182-023-00562-4","volume":"51","author":"T Tadele","year":"2023","unstructured":"Tadele T, Astatkie A, Tadesse BT, Makonnen E, Aklillu E, Abay SM. Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among preschool age children in southern Ethiopia. Trop Med Health. 2023;51(1):72. https:\/\/doi.org\/10.1186\/s41182-023-00562-4.","journal-title":"Trop Med Health"},{"key":"14051_CR11","unstructured":"Ministry of Health. Kenya national master plan for the elimination of neglected tropical diseases. (2023\u20132027). Ministry of Health; 2023. https:\/\/www.afro.who.int\/countries\/kenya\/publication\/kenya-national-master-plan-elimination-neglected-tropical-diseases-2023-2027. Accessed 15 Apr 2025."},{"key":"14051_CR12","doi-asserted-by":"publisher","unstructured":"Kepha S, Ochol D, Wakesho F, Omondi W, Njenga SM, Njaanake K, et al. Precision mapping of schistosomiasis and soil-transmitted helminthiasis among school age children at the coastal region, Kenya. Ekpo UF, editor. PLoS Negl Trop Dis. 2023;17(1):e0011043. https:\/\/doi.org\/10.1371\/journal.pntd.0011043.","DOI":"10.1371\/journal.pntd.0011043"},{"key":"14051_CR13","doi-asserted-by":"publisher","unstructured":"Okoyo C, Campbell SJ, Williams K, Simiyu E, Owaga C, Mwandawiro C. Prevalence, intensity and associated risk factors for soil-transmitted helminth and schistosome infections in Kenya: Impact assessment after five rounds of mass drug administration in Kenya. Montresor A, editor. PLoS Negl Trop Dis. 2020;14(10):e0008604. https:\/\/doi.org\/10.1371\/journal.pntd.0008604.","DOI":"10.1371\/journal.pntd.0008604"},{"issue":"1","key":"14051_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13071-021-04905-0","volume":"14","author":"JC Dejon-Agob\u00e9","year":"2021","unstructured":"Dejon-Agob\u00e9 JC, Zinsou JF, Honkpehedji YJ, Edoa JR, Adegbit\u00e9 BR, Beh-Mba R, et al. Knowledge, attitudes and practices pertaining to urogenital schistosomiasis in Lambar\u00e9n\u00e9 and surrounding areas. Gabon Parasites Vectors. 2021;14(1):486. https:\/\/doi.org\/10.1186\/s13071-021-04905-0.","journal-title":"Gabon Parasites Vectors"},{"issue":"1","key":"14051_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41182-024-00584-6","volume":"52","author":"G Alemu","year":"2024","unstructured":"Alemu G, Nibret E, Amor A, Munshea A, Anegagrie M. Knowledge, attitude and practice toward intestinal schistosomiasis among school-aged children and adults in Amhara Regional State, northwest Ethiopia. A cross-sectional study. Trop Med Health. 2024;52(1):23. https:\/\/doi.org\/10.1186\/s41182-024-00584-6.","journal-title":"Trop Med Health"},{"key":"14051_CR16","doi-asserted-by":"publisher","first-page":"1669964","DOI":"10.3389\/fitd.2025.1669964","volume":"6","author":"DT Naabil","year":"2025","unstructured":"Naabil DT, Tsekpo D, Manyeh AK. Assessing knowledge, attitude and preventive practices of schistosomiasis among nursing and midwifery students in the Hohoe nursing and midwifery training college, Ghana. Front Trop Dis. 2025;6:1669964. https:\/\/doi.org\/10.3389\/fitd.2025.1669964.","journal-title":"Front Trop Dis"},{"key":"14051_CR17","doi-asserted-by":"publisher","unstructured":"Gloria Kakoba A, Omara D, Wananda Y, Nambatya J, Charles Okiria J, Edielu A. Determinants of uptake of mass drug administration for schistosomiasis control in Butiaba Subcounty, Uganda. IJTDH. 2023;26\u201342. https:\/\/doi.org\/10.9734\/ijtdh\/2023\/v44i31393.","DOI":"10.9734\/ijtdh\/2023\/v44i31393"},{"key":"14051_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijid.2021.08.063","volume":"112","author":"M Sangare","year":"2021","unstructured":"Sangare M, Berthe A, Dolo H, Diabat\u00e9 AF, Konipo FDN, Soumaoro L, et al. Evaluation of mass drug administration for schistosomiasis and soil-transmitted helminths in school-aged children in Bankass, Mali. Int J Infect Dis. 2021;112:196\u2013201. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.063.","journal-title":"Int J Infect Dis"},{"key":"14051_CR19","doi-asserted-by":"publisher","unstructured":"Woelfle M, Seerden JP, De Gooijer J, Pouwer K, Olliaro P, Todd MH. Resolution of praziquantel. Geary TG, editor. PLoS Negl Trop Dis. 2011;5(9):e1260. https:\/\/doi.org\/10.1371\/journal.pntd.0001260.","DOI":"10.1371\/journal.pntd.0001260"},{"issue":"2","key":"14051_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.glohj.2025.06.007","volume":"9","author":"O Ezezika","year":"2025","unstructured":"Ezezika O, Olorunbiyi O, Gong J, Surakat O, Ogoji J, Nebe O. Implementation of school-based mass drug administration of praziquantel in Nigeria: barriers, facilitators and opportunities for improvement. Global Health J. 2025;9(2):136\u201344. https:\/\/doi.org\/10.1016\/j.glohj.2025.06.007.","journal-title":"Global Health J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14051-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:39:58Z","timestamp":1792535998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14051"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14051-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the Kenyatta University Scientific and Ethical Review Unit (No. PKU\/3162\/13085), in accordance with the principles of the Declaration of Helsinki. The principal investigator also obtained a research permit from the National Council for Science and Technology (NACOSTI) (License No: NACOSTI\/P\/25\/4173447) and the Busia County Department of Health. Informed consent was obtained from all study participants before data collection through questionnaires. Assent forms were signed by minors and their parents or legal guardians.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1842"}}